共 50 条
- [1] Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal Structure[J]. MOLECULES, 2022, 27 (19):Jia, WenqingLuo, ShuyuZhao, WennanXu, WeirenZhong, YuxuKong, Dexin
- [2] Enhanced PI3K p110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a p110α-Selective PI3K Inhibitor[J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (01) : 60 - 70Brady, Samuel W.Zhang, JianSeok, DanielWang, HaiYu, Dihua
- [3] Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110α inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) : 7677 - 7687Kendall, Jackie D.Rewcastle, Gordon W.Frederick, RaphaelMawson, ClaireDenny, William A.Marshall, Elaine S.Baguley, Bruce C.Chaussade, ClaireJackson, Shaun P.Shepherd, Peter R.
- [4] Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (04): : 434 - 438Han, FangbinLin, SongwenLiu, PengLiu, XiujieTao, JingDeng, XiaobingYi, ChongqinXu, Heng
- [5] PI3K/p110δ is a novel therapeutic target in multiple myeloma[J]. BLOOD, 2010, 116 (09) : 1460 - 1468Ikeda, HiroshiHideshima, TeruFulciniti, MariateresaPerrone, GiuliaMiura, NaoyaYasui, HiroshiOkawa, YutakaKiziltepe, TanyelSanto, LoredanaVallet, SoniaCristea, DianaCalabrese, ElisabettaGorgun, GulluRaje, Noopur S.Richardson, PaulMunshi, Nikhil C.Lannutti, Brian J.Puri, Kamal D.Giese, Neill A.Anderson, Kenneth C.
- [6] Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4936 - 4948Jia, HongDai, GuangxiuSu, WeiguoXiao, KunWeng, JianyangZhang, ZhulinWang, QingYuan, TianhaiShi, FuyingZhang, ZhengChen, WeiSai, YangWang, JianLi, XiongCai, YuYu, JunRen, PingVenable, JenniferRao, TadimetiEdwards, James P.Bembenek, Scott D.
- [7] Comparing the Roles of the p110α and p110β Isoforms of PI3K in Signaling and Cancer[J]. PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 2, 2011, 347 : 55 - 77Ilic, NinaRoberts, Thomas M.
- [8] Discovery of novel class of alpha selective PI3K inhibitors[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254Garland, KeiraHanan, EmilyStaben, StevenBraun, Marie-GabrielleEdgar, KyleEndres, NickFriedman, LoriNguyen, AmandaPang, JodiePurkey, HansSalphati, LaurentSchmidt, StephenSong, KyungUltsch, MarkJaochico, AllanChan, ConnieEigenbrot, CharlesMacLeod, CalumJackson, PhilipNarukulla, RamanKnight, JamieYeap, KuenMessick, KristenValle, NicoleHeald, RobertNannini, MichelleHamilton, PatClausen, SaundraYoung, AmySampath, DeepakHong, RebeccaLee, Man-LingBlench, TobyElliott, RichardLu, AijunGu, Xiao-HuXin, Jianfeng
- [9] Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (13) : 3030 - 3035Barlaam, BernardCosulich, SabinaFitzek, MartinaGermain, HerveGreen, StephenHanson, Lyndsey L.Harris, Craig S.Hancox, UrsHudson, KevinLambert-van der Brempt, ChristineLamorlette, MaryannickMagnien, FrancoiseOuvry, GillesPage, KenRuston, LinetteWard, LaraDelouvrie, Benedicte
- [10] Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 9 - 17Ma, Chen-ChenZhang, Cheng-MeiTang, Long-QianLiu, Zhao-Peng